{"title":"Can Anti-Ribosomal Antibodies Improve Systemic Lupus Erythematosus Diagnosis?","authors":"Elena Kokuina","doi":"10.37757/MR2021.V23.N1.15","DOIUrl":null,"url":null,"abstract":"Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology. The only means of reducing its morbidity and mortality remains early diagnosis followed by timely medical treatment. SLE affects all populations worldwide, although prevalence rates differ between population groups, with higher rates among women of reproductive age and for African, Asian, and Hispanic ethnicities.[1]","PeriodicalId":49835,"journal":{"name":"Medicc Review","volume":"23 1","pages":"90-91"},"PeriodicalIF":1.8000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicc Review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37757/MR2021.V23.N1.15","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology. The only means of reducing its morbidity and mortality remains early diagnosis followed by timely medical treatment. SLE affects all populations worldwide, although prevalence rates differ between population groups, with higher rates among women of reproductive age and for African, Asian, and Hispanic ethnicities.[1]
期刊介绍：
Uphold the highest standards of ethics and excellence, publishing open-access articles in English relevant to global health equity that offer the best of medical, population health and social sciences research and perspectives by Cuban and other developing-country professionals.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
